title: Individual decisions in placenta increta and percreta: a case series.
abstract: OBJECTIVE
  Placenta increta or percreta is an uncommon pathology, sometimes associated with high maternal morbidity. Its prevalence increases proportionally to the number of cesarean sections. This study analyzed the changes of our management strategy to devise treatment guidelines for this uncommon disorder.
  
  
  METHODS
  Between 2005 and 2011, 10 cases of placenta increta or percreta were managed at our university hospital maternity department.
  
  
  RESULTS
  Among the 10 cases, seven were diagnosed prenatally. Two patients were diagnosed early, at 14 and 17 weeks of gestational age, and their pregnancies were terminated. Five had hysterectomies during the intrapartum period, and despite attempted conservative treatment for the two others, hysterectomy proved necessary 2 months postpartum because of intrauterine infections. Seven of the 10 women had hysterectomies.
  
  
  CONCLUSIONS
  Prenatal diagnosis of placenta increta or percreta is essential to plan the delivery in a competent tertiary care center. The decision to perform a cesarean hysterectomy or leave the placenta in situ for spontaneous delivery is based on the extent of infiltration, the patient's hemodynamic status, and her desire to remain fertile. The high-risk of infection and severe hemorrhage must not be overlooked should conservative treatment be chosen. This situation requires prolonged close monitoring.
authors.affiliation: Department of Obstetrics and Gynecology, University of Liege, Liege, Belgium. fchantraine@chu.ulg.ac.be
authors.forename: Frédéric
authors.initials: F
authors.lastname: Chantraine
authors.forename: Michelle
authors.initials: M
authors.lastname: Nisolle
authors.forename: Philippe
authors.initials: P
authors.lastname: Petit
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Schaaps
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Foidart
mesh_terms: D000328:Adult; D002585:Cesarean Section / Q000009:adverse effects; D004107:Dilatation and Curettage / Q000009:adverse effects; D005260:Female; D006801:Humans; D007044:Hysterectomy; D010921:Placenta Accreta / Q000000981:diagnostic imaging / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D006473:Postpartum Hemorrhage / Q000209:etiology / Q000601:surgery; D011247:Pregnancy; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome; D016216:Ultrasonography, Prenatal; D055815:Young Adult